Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.
Aged
Colonoscopy
Colorectal Neoplasms
/ diagnosis
Early Detection of Cancer
/ standards
Feces
/ chemistry
Female
Follow-Up Studies
Hemoglobins
/ analysis
Humans
Immunohistochemistry
/ methods
Longitudinal Studies
Male
Middle Aged
Predictive Value of Tests
Retrospective Studies
Risk Assessment
/ methods
Risk Factors
Spain
/ epidemiology
Cancer
Cancer screening
Colon neoplasms
Fecal occult blood test
Journal
European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Titre abrégé: Eur J Cancer
Pays: England
ID NLM: 9005373
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
07
08
2018
revised:
28
10
2018
accepted:
01
11
2018
pubmed:
14
12
2018
medline:
6
5
2020
entrez:
14
12
2018
Statut:
ppublish
Résumé
Increased values in the fecal immunochemical test (FIT) are correlated with increasingly severe colorectal neoplasia, but little attention has been given to FIT values below the cut-off point (negative FIT, nFIT). We analysed the relationship between the concentrations of two consecutive nFIT and the risk of following screen-detected advanced neoplasia and interval cancer (IC) in a population-based colorectal cancer screening program. FIT results were categorised into non-detectable nFIT (0-3.8 μg haemoglobin/g feces), low nFIT (3.9-9.9) and high nFIT (10.0-19.9). Multivariable adjusted logistic regression was used to estimate the odds ratios (OR) of advanced neoplasia and IC with the nFIT results in the first two screens. More than 90% of the 42,524 persons had non-detectable nFIT in the first and second screen; 4.5% and 5.8% had a low nFIT, respectively, and 2.2% and 2.9% had a high nFIT. The probability of testing positive and being diagnosed of advanced neoplasia or IC rose with increasing values of nFIT. Compared with those with two non-detectable nFIT results, the highest OR were found among those who had two high nFIT results (OR 21.75; 95% confidence interval: 12.44, 38.04) and those with one low nFIT and one high nFIT (ORs around 20). Participants with nFIT results above the detection limit of the test had an increased risk of advanced neoplasia and IC in subsequent participations. This information could be used in the design of personalised screening strategies.
Identifiants
pubmed: 30544059
pii: S0959-8049(18)31465-5
doi: 10.1016/j.ejca.2018.11.004
pii:
doi:
Substances chimiques
Hemoglobins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
53-59Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.